FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008281569> ?p ?o ?g. }

• W2008281569 endingPage "145" @default.
• W2008281569 startingPage "137" @default.
• W2008281569 abstract "Apolipoprotein (apo) C-III plays an important role in regulating plasma triglyceride (TG) metabolism. In order to further investigate the plasma metabolism of apoC-III in hypertriglyceridemic subjects, we have studied the plasma kinetics of VLDL apoC-III, HDL apoC-III and total plasma apoC-III with a primed constant intravenous infusion of deuterated leucine in a group of male patients with mixed hyperlipidemia (type IIb hyperlipoproteinemia, HLP, n = 6) and in a group with type III HLP (n = 6). Compared to normolipidemic control subjects (n = 5), patients with type IIb and type III HLP had significantly higher levels of plasma TG (0.89 ± 0.15 mmol/l vs 2.56 ± 0.40 mmol/l vs 8.76 ± 1.39 mmol/l, respectively, P < 0.01), plasma apoC-III (9.5 ± 0.8 mg/dl vs 20.8 ± 2.5 mg/dl vs 41.7 ± 5.6 mg/dl, P < 0.01) and VLDL apoC-III (3.6 ± 0.8 mg/dl vs 14.6 ± 2.2 mg/dl vs 35.4 ± 5.1 mg/dl, P < 0.01). VLDL apoC-III production rates were significantly elevated in type IIb and type III patients (1.35 ± 0.23 mg kg−1 day−1 vs 3.53 ± 0.43 mg kg−1 day−1 vs 5.60 ± 0.78 mg kg−1 day−1, P < 0.01), as were total plasma apoC-III production rates (1.80 ± 0.22 mg kg−1 day−1 vs 4.16 ± 0.44 mg kg−1 day−1 vs 7.26 ± 0.74 mg kg−1 day−1, P < 0.01). VLDL apoC-III but not total plasma apoC-III fractional catabolic rates were reduced in type IIb and type III patients. Together with our previous results showing an increase of apoC-III production in patients with type IV HLP, and in overweight subjects with reduced insulin sensitivity, our data suggest that increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia." @default.
• W2008281569 created "2016-06-24" @default.
• W2008281569 creator A5022738765 @default.
• W2008281569 creator A5023567192 @default.
• W2008281569 creator A5026489514 @default.
• W2008281569 creator A5039852039 @default.
• W2008281569 creator A5053825317 @default.
• W2008281569 creator A5067772672 @default.
• W2008281569 creator A5070770963 @default.
• W2008281569 creator A5090786308 @default.
• W2008281569 date "2004-11-01" @default.
• W2008281569 modified "2023-09-26" @default.
• W2008281569 title "Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia" @default.
• W2008281569 cites W1527680278 @default.
• W2008281569 cites W1564265361 @default.
• W2008281569 cites W1607120480 @default.
• W2008281569 cites W1900613292 @default.
• W2008281569 cites W1963872182 @default.
• W2008281569 cites W1965505708 @default.
• W2008281569 cites W1977395120 @default.
• W2008281569 cites W1990644427 @default.
• W2008281569 cites W1994130325 @default.
• W2008281569 cites W1997090264 @default.
• W2008281569 cites W1997542488 @default.
• W2008281569 cites W1999294727 @default.
• W2008281569 cites W2006705370 @default.
• W2008281569 cites W2009316979 @default.
• W2008281569 cites W2010475848 @default.
• W2008281569 cites W2013694272 @default.
• W2008281569 cites W2020885344 @default.
• W2008281569 cites W2029164903 @default.
• W2008281569 cites W2033886436 @default.
• W2008281569 cites W2040805488 @default.
• W2008281569 cites W2041941025 @default.
• W2008281569 cites W2047589448 @default.
• W2008281569 cites W2059589608 @default.
• W2008281569 cites W2082672996 @default.
• W2008281569 cites W2083811960 @default.
• W2008281569 cites W2092138949 @default.
• W2008281569 cites W2093287637 @default.
• W2008281569 cites W2096432979 @default.
• W2008281569 cites W2098620654 @default.
• W2008281569 cites W2114808162 @default.
• W2008281569 cites W2129950813 @default.
• W2008281569 cites W2131037449 @default.
• W2008281569 cites W2135922747 @default.
• W2008281569 cites W2136213395 @default.
• W2008281569 cites W2143340286 @default.
• W2008281569 cites W2148326332 @default.
• W2008281569 cites W2155238815 @default.
• W2008281569 cites W2160942744 @default.
• W2008281569 cites W2164445076 @default.
• W2008281569 cites W2169761191 @default.
• W2008281569 cites W2170750385 @default.
• W2008281569 cites W2185343095 @default.
• W2008281569 cites W2327077996 @default.
• W2008281569 cites W2334791394 @default.
• W2008281569 cites W2346531204 @default.
• W2008281569 cites W2403507619 @default.
• W2008281569 cites W2415615490 @default.
• W2008281569 doi "https://doi.org/10.1016/j.atherosclerosis.2004.06.011" @default.
• W2008281569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15488876" @default.
• W2008281569 hasPublicationYear "2004" @default.
• W2008281569 type Work @default.
• W2008281569 sameAs 2008281569 @default.
• W2008281569 citedByCount "59" @default.
• W2008281569 countsByYear W20082815692012 @default.
• W2008281569 countsByYear W20082815692013 @default.
• W2008281569 countsByYear W20082815692014 @default.
• W2008281569 countsByYear W20082815692015 @default.
• W2008281569 countsByYear W20082815692016 @default.
• W2008281569 countsByYear W20082815692017 @default.
• W2008281569 countsByYear W20082815692019 @default.
• W2008281569 countsByYear W20082815692020 @default.
• W2008281569 countsByYear W20082815692021 @default.
• W2008281569 crossrefType "journal-article" @default.
• W2008281569 hasAuthorship W2008281569A5022738765 @default.
• W2008281569 hasAuthorship W2008281569A5023567192 @default.
• W2008281569 hasAuthorship W2008281569A5026489514 @default.
• W2008281569 hasAuthorship W2008281569A5039852039 @default.
• W2008281569 hasAuthorship W2008281569A5053825317 @default.
• W2008281569 hasAuthorship W2008281569A5067772672 @default.
• W2008281569 hasAuthorship W2008281569A5070770963 @default.
• W2008281569 hasAuthorship W2008281569A5090786308 @default.
• W2008281569 hasConcept C126322002 @default.
• W2008281569 hasConcept C134018914 @default.
• W2008281569 hasConcept C185592680 @default.
• W2008281569 hasConcept C2776919658 @default.
• W2008281569 hasConcept C2778163477 @default.
• W2008281569 hasConcept C2778913445 @default.
• W2008281569 hasConcept C2779091943 @default.
• W2008281569 hasConcept C2780072125 @default.
• W2008281569 hasConcept C555293320 @default.
• W2008281569 hasConcept C62231903 @default.
• W2008281569 hasConcept C62746215 @default.
• W2008281569 hasConcept C71924100 @default.
• W2008281569 hasConcept C8243546 @default.
• W2008281569 hasConceptScore W2008281569C126322002 @default.

• next